JP Morgan Initiates Coverage On GE HealthCare Techs with Neutral Rating, Announces Price Target of $90
Portfolio Pulse from Benzinga Newsdesk
JP Morgan has initiated coverage on GE HealthCare Techs with a Neutral rating and set a price target of $90.
September 09, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has initiated coverage on GE HealthCare Techs with a Neutral rating and a price target of $90, indicating a balanced view on the stock's potential.
The Neutral rating suggests that JP Morgan sees no strong catalysts for significant price movement in the short term. The price target of $90 provides a benchmark for investors, indicating that the stock is fairly valued at current levels.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100